The Albanese Labor Government is delivering on its election commitment to support biomanufacturing in Queensland.
Minister for Industry and Science Ed Husic said the Budget included $12.6 million to support Cytiva’s Springfield BioPark Australia project in Ipswich.
This will help Cytiva buy new equipment to expand its biomanufacturing capabilities for high-value medicines.
“The Albanese Government was elected with a mandate to revitalise Australian manufacturing, with a strong focus on supporting regional development,” Minister Husic said.
“We want Australia to be a country that makes things, now and well into the future.
Top Australian Brokers
“That includes advanced manufacturing and the biotechnology that is at the heart of Cytiva’s business.”
Minister Husic said the investment would support jobs and help industry secure domestic supply chains, clinical trials, and research and development.
Federal Member for Blair Shayne Neumann said he was delighted the Albanese Government’s first Budget delivered on the commitment to the Springfield BioPark project.
“This investment will boost advanced manufacturing of critical therapies and vaccines here in Ipswich, supporting local jobs.
“The Springfield BioPark will be a real game-changer with so many benefits for Ipswich and Queensland,” Mr Neumann said.
Federal Member for Oxley Milton Dick said Queensland has always been the ‘Smart State’, and the Albanese Government was investing in new industries and well-paid, skilled jobs in the Western Corridor, one of the fastest growing regions in the country.
“I’ve made clear I want to drive advanced manufacturing in Greater Springfield – to bring business and community together to boost investment and jobs in the region, so I’m proud to see this commitment delivered by the Federal Government,” Mr Dick said.
The $12.6 million investment is one of eight targeted industry grants the Albanese Government delivered in the Budget to support local industry, economic growth and job creation.
The Springfield BioPark Australia project will boost Australia’s sovereign capability in medical manufacturing, including mRNA vaccine production, which will support the country’s future pandemic preparedness.
Springfield City Group, Cytiva and other partners are working together to deliver the project.